HRP20171393T1 - Postupak za staničnu ekspresiju rnk - Google Patents

Postupak za staničnu ekspresiju rnk Download PDF

Info

Publication number
HRP20171393T1
HRP20171393T1 HRP20171393TT HRP20171393T HRP20171393T1 HR P20171393 T1 HRP20171393 T1 HR P20171393T1 HR P20171393T T HRP20171393T T HR P20171393TT HR P20171393 T HRP20171393 T HR P20171393T HR P20171393 T1 HRP20171393 T1 HR P20171393T1
Authority
HR
Croatia
Prior art keywords
cells
pkr
rna
properties
fibroblasts
Prior art date
Application number
HRP20171393TT
Other languages
English (en)
Croatian (hr)
Inventor
Ugur Sahin
Tim Beissert
Marco Poleganov
Stephanie Herz
Original Assignee
Biontech Rna Pharmaceuticals Gmbh
Translationale Onkologie An Der Universitätsmedizin Der Jgu Mainz Ggmbh (Tron)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2010/007362 external-priority patent/WO2012072096A1/fr
Application filed by Biontech Rna Pharmaceuticals Gmbh, Translationale Onkologie An Der Universitätsmedizin Der Jgu Mainz Ggmbh (Tron) filed Critical Biontech Rna Pharmaceuticals Gmbh
Publication of HRP20171393T1 publication Critical patent/HRP20171393T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HRP20171393TT 2010-12-03 2011-12-02 Postupak za staničnu ekspresiju rnk HRP20171393T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2010/007362 WO2012072096A1 (fr) 2010-12-03 2010-12-03 Procédé pour l'expression cellulaire d'arn
EP11791447.3A EP2646557B1 (fr) 2010-12-03 2011-12-02 Procédé pour l'expression cellulaire d'arn
PCT/EP2011/006061 WO2012072269A1 (fr) 2010-12-03 2011-12-02 Procédé pour l'expression cellulaire d'arn

Publications (1)

Publication Number Publication Date
HRP20171393T1 true HRP20171393T1 (hr) 2017-11-17

Family

ID=45644286

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20171393TT HRP20171393T1 (hr) 2010-12-03 2011-12-02 Postupak za staničnu ekspresiju rnk

Country Status (8)

Country Link
EP (2) EP3282015B1 (fr)
CY (1) CY1119355T1 (fr)
HR (1) HRP20171393T1 (fr)
ME (1) ME02871B (fr)
PL (1) PL2646557T3 (fr)
RS (1) RS56419B1 (fr)
SI (1) SI2646557T1 (fr)
SM (1) SMT201700446T1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL126757A0 (en) * 1998-09-07 1999-08-17 Yissum Res Dev Co Regulation of gene expression through manipulation of mRNA splicing and its uses
ATE450621T2 (de) 2000-03-30 2009-12-15 Whitehead Biomedical Inst Mediatoren von rns-interferenz, die rns- sequenzspezifisch sind
GB0104948D0 (en) * 2001-02-28 2001-04-18 Novartis Res Foundation Novel methods
CN102272291B (zh) * 2008-10-31 2018-01-16 詹森生物科技公司 人胚胎干细胞向胰腺内分泌谱系的分化
WO2012072096A1 (fr) * 2010-12-03 2012-06-07 Biontech Ag Procédé pour l'expression cellulaire d'arn

Also Published As

Publication number Publication date
CY1119355T1 (el) 2018-02-14
EP2646557B1 (fr) 2017-08-09
EP3282015A3 (fr) 2018-02-21
EP3282015A2 (fr) 2018-02-14
ME02871B (fr) 2018-04-20
RS56419B1 (sr) 2018-01-31
PL2646557T3 (pl) 2017-12-29
SMT201700446T1 (it) 2017-11-15
SI2646557T1 (sl) 2017-11-30
EP2646557A1 (fr) 2013-10-09
EP3282015B1 (fr) 2020-05-20

Similar Documents

Publication Publication Date Title
PT2646557T (pt) Método para expressão de arn celular
ES2741806T3 (es) Un método para la diferenciación directa de células madre pluripotentes en músculo cardíaco funcional
WO2007115336A3 (fr) Approche basée sur la forme pour ingéniérie tissulaire sans échafaudage
WO2007127927A3 (fr) Différentiation de cellules souches embryonnaires humaines
WO2009012428A3 (fr) Différenciation de cellules souches embryonnaires humaines
WO2005097977A3 (fr) Differenciation de cellules souches en lignee endodermique et pancreatique
BRPI0922355A2 (pt) ácidos nucléicos, métodos para reduzir a expressão de um gene em uma célula in vitro, uso de um ácido nucléico, complexo de rna e uso do complexo de rna
NZ630598A (en) Method of engrafting cells from solid tissues
WO2005062820A3 (fr) Systeme a plasmides multiples pour la production du virus de la grippe
WO2009145419A9 (fr) Composition comprenant de la peptone végétale pour favoriser la prolifération de cellules souches
WO2005042728A3 (fr) Lignees de cellules aviaires immortalisees pour la production de virus
EA201792036A1 (ru) Способ осуществления сайт-направленной модификации растительных геномов с использованием ненаследуемых материалов
MX2010001335A (es) Diferenciacion de celulas madre embrionarias humanas.
MX2020011807A (es) Composiciones y metodos para inhibir la expresion genica del virus de hepatitis b.
JP2011068660A5 (fr)
EP1679964A4 (fr) Compositions et methodes utilisant un arnsi, des composes amphipathiques et des polycations
WO2013093352A3 (fr) Procede de fabrication d'un noyau ceramique pour aube mobile, noyau ceramique, aube mobile
WO2009022656A1 (fr) Cellules de mammifère recombinantes, procédé de production de cellules de mammifère recombinantes, et procédé de production d'une protéine cible
WO2006034368A3 (fr) Microarns (miarns) pour la croissance et le developpement de plantes
WO2013003282A3 (fr) Utilisation d'un masque perforé et d'un masque souple destinés à des implants alignés dans des cellules solaires
AR069885A1 (es) Metodos para producir el virus de estomatitis vesicular (vsv) atenuado en un cultivo celular y para mejorar el empaque del vsv de propagacion defectuosa, composicion inmunogenica, celula aislada y secuencia de control transcripcional
NZ599479A (en) Improved reverse genetics methods for virus rescue
AR073800A1 (es) Tratamiento de la infeccion del virus de la hepatitis c con sobreexpresion de micro rna -196
BRPI0914805B8 (pt) método para replicar vírus em uma cultura de células scldk, processo para adaptar células cldk dependentes do substrato para desenvolvimento em suspensão, método para propagar continuamente células scldk em suspensão, e, composição
ME02871B (fr) Procédé pour l'expression cellulaire d'arn